Withdrawal of Registration Statement (ammendment) (aw)
26 March 2022 - 7:31AM
Edgar (US Regulatory)
Indaptus
Therapeutics, Inc.
3
Columbus Circle, 15th Floor
New
York, NY 10019
March
25, 2022
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re: |
Indaptus
Therapeutics, Inc. |
|
Registration
Statement on Form S-1 |
|
Post-Effective
Amendment No. 1 |
|
File
No. 333-230016 |
Ladies
and Gentlemen:
Pursuant
to Rule 477 under the Securities Act of 1933, as amended (the “1933 Act”), Indaptus Therapeutics, Inc. (the “Company”)
hereby requests that the Securities and Commission (the “Commission”) consent to the withdrawal of the Post-Effective Amendment
No. 1 (SEC Accession No. 0001493152-22-007380) to the Company’s Registration Statement on Form S-1 (File No. 333-230016),
together with all exhibits filed therewith, filed on March 21, 2022 (the “Post-Effective Amendment”). The Post-Effective
Amendment referenced and was inadvertently filed under the 1933 Act file number 333-230016. The Company re-filed the Post-Effective Amendment
referencing and under the 1933 Act file number 333-259771 on March 22, 2022 (SEC Accession No. 0001493152-22-007456). The withdrawal
is requested only for the Post-Effective Amendment and not with respect to any other filings made under the 1933 Act file number 333-230016.
The Post-Effective Amendment has not been declared effective by the Commission and no securities have been sold under the Post-Effective
Amendment.
Please
direct any questions or comments regarding this correspondence to Gary Emmanuel of McDermott Will & Emery LLP at (212) 547-5541.
Thank
you for your assistance in this matter.
|
Very
truly yours, |
|
|
|
INDAPTUS
THERAPEUTICS, INC. |
|
|
|
|
By:
|
/s/
Jeffrey A. Meckler |
|
Name:
|
Jeffrey
A. Meckler |
|
Title:
|
Chief
Executive Officer |
Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Jul 2023 to Jul 2024